Trials for Cerebellar Ataxias From Cellular Models to Human Therapies /

Despite the critical importance of the cerebellum in brain functions, the scientific community still lacks effective treatments for most cerebellar ataxias. This book provides a link between the pathogenesis and therapies of cerebellar ataxias while also providing a comprehensive assessment of the p...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Korporacja: SpringerLink (Online service)
Kolejni autorzy: Soong, Bing-wen (Redaktor), Manto, Mario (Redaktor), Brice, Alexis (Redaktor), Pulst, Stefan M. (Redaktor)
Format: Elektroniczne E-book
Język:angielski
Wydane: Cham : Springer International Publishing : Imprint: Springer, 2023.
Wydanie:1st ed. 2023.
Seria:Contemporary Clinical Neuroscience,
Hasła przedmiotowe:
Dostęp online:https://doi.org/10.1007/978-3-031-24345-5
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
Spis treści:
  • Part I: Basic Science of Cerebellum and Ataxias
  • Functional anatomy of the cerebellum
  • Cerebellar physiology
  • Cerebellar biochemistry/pharmacology
  • Genetics of dominant ataxias
  • Autosomal and X-linked degenerative ataxias: from genetics to promising therapeutics
  • Seeking therapies for Spinocerebellar Ataxia: from gene silencing to systems-based approaches
  • Ion Channel Genes and Ataxia
  • Part II: Biomarkers and tools of trials
  • How to Design a Therapeutic Trial in SCAs
  • Therapy development for spinocerebellar ataxia: Rating Scales and Biomarkers
  • Clinical rating scales for ataxia
  • Scale for Ocular motor Disorders in Ataxia (SODA): Procedures and Basic Understanding
  • Cerebellar learning in the prism adaptation task
  • Blood and CSF biomarkers in autosomal dominant cerebellar ataxias
  • Part III: Autosomal Dominant Cerebellar Ataxias
  • Riluzole in progressive cerebellar ataxias
  • ASOs against ATXN2 in preclinical and phase 1 trials
  • Antisense oligonucleotide therapy against SCA3
  • Spinocerebellar ataxia type 7: From mechanistic pathways to therapeutic opportunities
  • Experimental neurotransplantation for cerebellar ataxias
  • Development of mesenchymal stem cells therapy for the treatment of polyglutamine SCA: from bench to bedside
  • Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia
  • Cerebellar Transcranial Magnetic Stimulation in Cerebellar Ataxias
  • Physical therapy in Cerebellar Ataxia
  • Part IV: Autosomal Recessive Cerebellar Ataxias
  • Recent advances on therapeutic approaches for Friedreich’s Ataxia
  • Therapeutic use of interferon gamma in Friedreich ataxia
  • Metabolic treatments of cerebellar ataxia
  • Clinical Trials in Fragile X-Associated Tremor/Ataxia Syndrome
  • Part V: Sporadic Ataxias
  • Therapeutic strategies inimmune-mediated cerebellar ataxias
  • Coenzyme Q10 in MSA
  • State of the Art and History of Therapeutics in Ataxias.